Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

U.S. Headed for War with China

According to a professor at Renmin University the stability…
Read more

“Climate Change” No Cause for Alarm

According to Dr. Indur Goklany argues that, assuming global…
Read more

Democrats Defeat Amendment Protecting Babies Who Survive Abortion

After a senate vote, the senate Democrats grimly defeated…
Read more